137 related articles for article (PubMed ID: 38109371)
21. In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response.
Bathen TF; Heldahl MG; Sitter B; Vettukattil R; Bofin A; Lundgren S; Gribbestad IS
MAGMA; 2011 Dec; 24(6):347-57. PubMed ID: 21909791
[TBL] [Abstract][Full Text] [Related]
22. Choline metabolic profiling by magnetic resonance spectroscopy.
Iorio E; Ricci A; Pisanu ME; Bagnoli M; Podo F; Canevari S
Methods Mol Biol; 2013; 1049():255-70. PubMed ID: 23913222
[TBL] [Abstract][Full Text] [Related]
23. Biochemical characterization of breast tumors by in vivo and in vitro magnetic resonance spectroscopy (MRS).
Sharma U; Jagannathan NR
Biophys Rev; 2009 Mar; 1(1):21. PubMed ID: 28510152
[TBL] [Abstract][Full Text] [Related]
24. A novel roadmap connecting the
Iorio E; Podo F; Leach MO; Koutcher J; Blankenberg FG; Norfray JF
Eur Radiol Exp; 2021 Jan; 5(1):5. PubMed ID: 33447887
[TBL] [Abstract][Full Text] [Related]
25. Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models.
Moestue SA; Borgan E; Huuse EM; Lindholm EM; Sitter B; Børresen-Dale AL; Engebraaten O; Maelandsmo GM; Gribbestad IS
BMC Cancer; 2010 Aug; 10():433. PubMed ID: 20716336
[TBL] [Abstract][Full Text] [Related]
26. In vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian Cancer.
Canese R; Mezzanzanica D; Bagnoli M; Indraccolo S; Canevari S; Podo F; Iorio E
Front Oncol; 2016; 6():164. PubMed ID: 27446810
[TBL] [Abstract][Full Text] [Related]
27. Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors.
Herminghaus S; Pilatus U; Möller-Hartmann W; Raab P; Lanfermann H; Schlote W; Zanella FE
NMR Biomed; 2002 Oct; 15(6):385-92. PubMed ID: 12357552
[TBL] [Abstract][Full Text] [Related]
28. Comparison of in vivo and in situ detection of hippocampal metabolites in mouse brain using
Hsu CH; Lin S; Ho AC; Johnson TD; Wang PC; Scafidi J; Tu TW
NMR Biomed; 2021 Feb; 34(2):e4451. PubMed ID: 33258202
[TBL] [Abstract][Full Text] [Related]
29. Metabolite changes in HT-29 xenograft tumors following HIF-1alpha inhibition with PX-478 as studied by MR spectroscopy in vivo and ex vivo.
Jordan BF; Black K; Robey IF; Runquist M; Powis G; Gillies RJ
NMR Biomed; 2005 Nov; 18(7):430-9. PubMed ID: 16206237
[TBL] [Abstract][Full Text] [Related]
30. Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy.
Swanson MG; Zektzer AS; Tabatabai ZL; Simko J; Jarso S; Keshari KR; Schmitt L; Carroll PR; Shinohara K; Vigneron DB; Kurhanewicz J
Magn Reson Med; 2006 Jun; 55(6):1257-64. PubMed ID: 16685733
[TBL] [Abstract][Full Text] [Related]
31. The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy.
Al-Saffar NM; Jackson LE; Raynaud FI; Clarke PA; Ramírez de Molina A; Lacal JC; Workman P; Leach MO
Cancer Res; 2010 Jul; 70(13):5507-17. PubMed ID: 20551061
[TBL] [Abstract][Full Text] [Related]
32. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapy.
Choi JS; Baek HM; Kim S; Kim MJ; Youk JH; Moon HJ; Kim EK; Nam YK
PLoS One; 2013; 8(12):e83866. PubMed ID: 24367616
[TBL] [Abstract][Full Text] [Related]
34. The response of RIF-1 fibrosarcomas to the vascular-disrupting agent ZD6126 assessed by in vivo and ex vivo 1H magnetic resonance spectroscopy.
Madhu B; Waterton JC; Griffiths JR; Ryan AJ; Robinson SP
Neoplasia; 2006 Jul; 8(7):560-7. PubMed ID: 16867218
[TBL] [Abstract][Full Text] [Related]
35. Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS.
Jensen LR; Huuse EM; Bathen TF; Goa PE; Bofin AM; Pedersen TB; Lundgren S; Gribbestad IS
NMR Biomed; 2010 Jan; 23(1):56-65. PubMed ID: 19650073
[TBL] [Abstract][Full Text] [Related]
36. Clinical relevance of total choline (tCho) quantification in suspicious lesions on multiparametric breast MRI.
Sodano C; Clauser P; Dietzel M; Kapetas P; Pinker K; Helbich TH; Gussew A; Baltzer PA
Eur Radiol; 2020 Jun; 30(6):3371-3382. PubMed ID: 32065286
[TBL] [Abstract][Full Text] [Related]
37. Impact of Freezing Delay Time on Tissue Samples for Metabolomic Studies.
Haukaas TH; Moestue SA; Vettukattil R; Sitter B; Lamichhane S; Segura R; Giskeødegård GF; Bathen TF
Front Oncol; 2016; 6():17. PubMed ID: 26858940
[TBL] [Abstract][Full Text] [Related]
38. HR-MAS MR spectroscopy of breast cancer tissue obtained with core needle biopsy: correlation with prognostic factors.
Choi JS; Baek HM; Kim S; Kim MJ; Youk JH; Moon HJ; Kim EK; Han KH; Kim DH; Kim SI; Koo JS
PLoS One; 2012; 7(12):e51712. PubMed ID: 23272149
[TBL] [Abstract][Full Text] [Related]
39. In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.
Sardanelli F; Fausto A; Di Leo G; de Nijs R; Vorbuchner M; Podo F
AJR Am J Roentgenol; 2009 Jun; 192(6):1608-17. PubMed ID: 19457825
[TBL] [Abstract][Full Text] [Related]
40. Metabolic profiling of ob/ob mouse fatty liver using HR-MAS
Gogiashvili M; Edlund K; Gianmoena K; Marchan R; Brik A; Andersson JT; Lambert J; Madjar K; Hellwig B; Rahnenführer J; Hengstler JG; Hergenröder R; Cadenas C
Anal Bioanal Chem; 2017 Feb; 409(6):1591-1606. PubMed ID: 27896396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
